Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
McKinsey
AstraZeneca
McKesson
Queensland Health
Farmers Insurance
Moodys
Fish and Richardson
Chinese Patent Office

Generated: October 18, 2017

DrugPatentWatch Database Preview

HEPATAMINE 8% Drug Profile

« Back to Dashboard

What is the patent landscape for Hepatamine 8%, and what generic Hepatamine 8% alternatives are available?

Hepatamine 8% is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in HEPATAMINE 8% is amino acids. There are three hundred and forty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.

Summary for Tradename: HEPATAMINE 8%

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HEPATAMINE 8% at DailyMed

Pharmacology for Tradename: HEPATAMINE 8%

Ingredient-typeAmino Acids
Drug ClassAmino Acid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
HEPATAMINE 8%
amino acids
INJECTABLE;INJECTION018676-001Aug 3, 1982RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: HEPATAMINE 8%

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
B Braun
HEPATAMINE 8%
amino acids
INJECTABLE;INJECTION018676-001Aug 3, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
UBS
Fuji
Chinese Patent Office
Healthtrust
US Army
Farmers Insurance
Merck
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot